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The role of the RNA-binding protein human antigen R (HuR) in hepatocarcinogenesis is still elusive.
By employing short hairpin (sh)RNA-dependent knockdown approach, we demonstrate that lym-
photoxin a (LTa) is a target of posttranscriptional gene regulation by HuR in hepatocellular carci-
noma (HepG2) cells. Consequently, the increased mRNA decay upon HuR depletion signiﬁcantly
affects lymphotoxin expression at both, the mRNA and protein level. Biotin-pulldown assay showed
that HuR speciﬁcally interacts with the 30-untranslated region (30-UTR) of the LTa mRNA.
Furthermore, electrophoretic mobility shift assay (EMSA) implicates that the RNA-binding critically
depends on the RNA recognition motif 2 (RRM2) and the hinge region of HuR.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The RNA-binding protein HuR controls many aspects of post-
transcriptional processing of adenylate- and uridylate-rich ele-
ment (ARE)-bearing mRNA subsets including splicing, polyaden
ylation, mRNA-stabilization and translation [1,2]. The modulation
of these mRNA functions is mediated by an increased binding of
HuR to AREs residing in most cases within the 30-UTR of otherwise
labile mRNAs. Members of the Hu-protein family are characterized
by a unique structure of three highly conserved RNA recognition
motifs (RRMs) and a less conserved Hinge region between the
RRM2 and RRM3, which is highly relevant for the intracellularHuR localization and nucleo-cytoplasmic shuttling [2]. The two
N-terminal RRMs (RRM1 and RRM2) which represent the most
conserved RRMs among different Hu family members are proposed
as main RNA-binding domains whereas the carboxy (C)-terminal
RRM3 is mainly involved in protein–protein interactions and rele-
vant for stabilization of RNA–protein complexes. However, a cru-
cial role of this RRM for RNA binding has also been demonstrated
[2,3]. Since many HuR target mRNAs encode proteins implicated
in cancer-related cell functions [4–6], HuR has emerged as an
important posttranscriptional regulator of carcinogenesis. In line
with this concept, high HuR expression levels have been reported
in many human tumors concomitant with a high-grade malig-
nancy and a poor outcome [7–9]. In the liver HuR is implicated
in the regulation of hepatocyte proliferation, differentiation and
hepatocellular carcinoma (HCC) transformation [10,11].
Lymphotoxin a (LTa) is a member of the tumor necrosis factor
(TNF) superfamily which can either exist as a membrane-bound
heterodimer (LTa1b2), or as soluble homotrimer (LTa3) [12]. The
latter one signals mainly through binding to the TNF receptors
TNFRI and II and shares some biological activities with TNFa most
importantly, the activation of canonical and non-canonical NFjB
signaling cascades [13]. Although LTa is mainly secreted by acti-
vated immune cells and lymphoid tissue inducer cells sustained
LTa signaling is involved in chronic inﬂammation-induced liver
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trols hepatic stellate cell function and wound healing processes
which are critical for liver regeneration [14]. Given the tumorigenic
properties of LTa and HuR, we demonstrate that LTa is a direct tar-
get of posttranscriptional regulation by HuR. Furthermore, we
characterized the HuR-LTa mRNA interaction by different RNA
binding assays using various truncated HuR constructs.
2. Materials and methods
2.1. Materials
Actinomycin D (from Streptomyces species), and anti-b-tubulin
antibodies were purchased from Sigma–Aldrich (Deisenhofen,
Germany). Ribonucleotides and modifying enzymes were from
Life Technologies (Karlsruhe, Germany). Antibodies against triste-
traprolin (TTP) were from Abcam (Cambridge, UK). All the other
antibodies were from Santa Cruz Biotechnology (Heidelberg,
Germany). Protein G Sepharose, the ECL system and Hyperﬁlm
were from GE Healthcare (Freiburg, Germany). All cell culture
media and supplements were purchased from Life Technologies.
2.2. Cell culture
HepG2 human hepatocellular carcinoma cells were grown in
minimal essential medium (MEM) supplemented with 10% fetal
calf serum, 100 U/mL penicillin, 100 lg/mL streptomycin, 0.1 mM
non-essential amino acids and 1 mM sodium pyruvate. Serum free
preincubations were performed in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 0.1 mg/mL of fatty acid-free bovine
serum albumin. For constant selection shRNA transfected cells
were grown in medium supplemented with 2 lg/mL puromycin.
2.3. Stable knockdown of HuR
HepG2 cells stably expressing a HuR shRNA vector (‘‘HuR k/d
cells’’) andHepG2 cells expressinganon-target shRNA (ctr cells)were
generated by lentiviral transduction as described previously [15].
2.4. Western blot analysis
Cells were grown on 6 cm dishes, harvested in 100 ll lysis buf-
fer (20 mM Tris, pH 8.0, 137 mM NaCl, 5 mM EDTA, 10% glycerol,
1% Triton X-100) and lyzed by repeated cycles of freezing–thawing.
10–20 lg of protein per sample were separated on SDS–PAGE and
transferred onto Hybond nitrocellulose membrane (GE Healthca
re). After blocking in 2% BSA the membranes were probed with
speciﬁc antibodies and appropriate peroxidase-conjugated sec-
ondary antibodies. Immunoreactive bands were visualized with
chemiluminescence using an ECL system (GE Healthcare). Nucl
ear and cytoplasmic extracts from HepG2 cells were prepared by
using a protocol from Schreiber et al. [16].
2.5. Plasmid constructs
Expression plasmids for puriﬁcation of GST-tagged wild-type
HuR (HuR-wt) and different HuR truncations were a kind gift from
Prof. Dr. Chemnitz (University of Göttingen, Germany) and were
cloned as described previously [17].
2.6. Generation of plasmids bearing the 30-UTR of LTa for in vitro
transcription
The plasmid ‘‘pcDNA 3.1 30-UTRLTa’’ containing 584 bp of a
region from the wild-type 30-UTR of human LTamRNA was gener-
ated by using BamHI and Not I restriction sites (underlined) asfollowed: BamHI-ﬂanked (underlined) forward primer 50-ATA
GGA TCC GTC TTC TTT GGA GCC TTC GCT CTG-30 and
NotI-ﬂanked (underlined) reverse primer 50-ATA GCG GCC GCG
GCT TTC AGA GCC TTT CCC TGC-30, corresponding to a region from
nucleotide 805 to 1389 of the human LTa mRNA (GenBankTM
accession No. NM_001159740.2) directly into BamHI/Not I cut
pcDNA.3.1 vector. The plasmid ‘‘pcDNA 3.1. 30-UTR-LTa mut1/2’’
bearing point mutations in two adjacent ARE sites was generated
by site-directed mutagenesis using the following (sense) primers:
LTa mut1: 50-GGC AGG GAG GGG ACT ACC CAT GAA GGC AAA
AA-30, (corresponding to a region from 1175 to 1207) and LTa
mut2: 50-GAA GGC AAA AAA ACC AAA GGA CCT ATC CAT GGA
GGA TGG AGA GAG-30, corresponding to a region from 1196 to
1240 of the human LTa mRNA. All mutants were generated with
the Quick Change site-directed mutagenesis kit (Agilent
Technologies, Santa Clara, CA) and conﬁrmed by DNA sequencing.
2.7. Generation reporter plasmids and transient transfection of HepG2
cells
The plasmid psiCHECK2-LTa-30UTR was generated by cloning a
584 bp fragment from the 30UTR of human LTa mRNA into the
psiCHECK2 vector (Promega, Madison, WI). Using the XhoI-ﬂanked
(underlined) forward primer 50-ATA CTC GAG GTC TTC TTT GGA
GCC TTC GCT CTG-30 and NotI-ﬂanked (underlined) reverse primer
50-ATAGCGGCCGCGGCT TTCAGAGCCTTT CCCTGC-30 correspond-
ing to a region from nucleotide 805 to 1389 of the human LTa cDNA
(GeneBankaccessionNo.NM_001159740.2), the 30-UTR sequence of
human LTa gene was generated by PCR from reverse transcriptase
products and subsequently cloned into the XhoI/NotI cut
psiCHECK2 vector, thereby allowing a forced insertion at the 30end
of the Renilla luciferase coding region.
For transient transfection, cells were grown on six-well plates
and transfected with 400 ng of plasmid DNA using the
Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad,
CA). Cells were lysed for luciferase assay 24 h after transfection
and Luciferase assays were performed using the Dual-Luciferase
Reporter Assay System (Promega) according to the manufacturer’s
protocol and Fireﬂy luciferase was used for normalization.
2.8. Expression and puriﬁcation of HuR proteins
Expression and puriﬁcation of wild-type or different GST-HuR
deletion mutations was done as described previously [18].
2.9. RNA isolation and quantitative real-time PCR experiments
Total RNAwas extracted fromwhole cells byusing the Tri reagent
(Sigma–Aldrich) and ﬁrst strand cDNA was synthesized using ran-
dom hexamer primer and SuperScript reverse transcriptase
(Fermentas, St. Leon-Rot, Germany). Levels of speciﬁc cDNAs were
determined by semiquantitative PCR or two-step real-time PCR as
described previously [3]. For quantitative PCR, the C(T) values of
mRNA levels were normalized to the C(T)values of GAPDH mRNA
within the same sample. The following oligonucleotides were used
for PCR: HuR forward (50-CAC AGC TTG GGC TAC GGC TTT GTG-30),
andHuR reverse (50-AGGACCCGCGAGTTGATGATCCG-30), LTa for-
ward (50-ATG ACA CCA CCT GAA CGT CTC-30) and LTa reverse
(50-GGT CTC CAA TGA GGT GAG CA-30), COX-2 forward (50-TTC
AAA TGA GAT TGT GGG AAA ATT GCT-30), and COX-2 reverse
(50-AGA TCA TCT CTG CCT GAG TAT CTT-30), cyclin A forward
(50-ATT AGT TTA CCT GGA CCC AG-30), and cyclin A reverse (50-CAC
AAA CTC TGC TAC TTC TG-30), GAPDH forward (50-CAC CAT CTT
CCA GGA GCG AG-30), and GAPDH reverse (50-GCA GGA GGC ATT
CCT GAT-30).
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Immunoprecipitation of HuR was performed as described pre-
viously [3]. After washing the beads several times with bind-
ing/wash buffer (140 mM NaCl, 8 mM, K2HPO4, 2 mM Na3PO4,
10 mM KCl), the bound mRNA was extracted by addition of
1 mL Tri-reagent and reverse transcribed using SuperScript
reverse transcriptase (Fermentas), and subsequently subjected to
semiquantitative PCR by using gene-speciﬁc primers described
before. Normalization of input RNA was conﬁrmed by RT reaction
of total cellular RNA isolated from 10% of the cell extract used for
the IP.
2.11. Biotin pull-down assay
To generate biotinylated RNA sense probes for the biotin
pull-down assay, 20 lg of either linearized plasmid pcDNA 3.1
30-UTR-LTa or pcDNA 3.1 30-UTR-LTa mut1/2 were in vitro tran-
scribed and biotinylated as described previously [19].
2.12. Separation of polysomes from ribonucleoprotein particles (RNPs)
Separation of polysomes from RNPs was performed as described
previously [20]. The purity of both fractions was conﬁrmed by the
detection of the translation initiation factor eIF4A which is exclu-
sively found in polysomes but not in the fractions of translational
inactive RNPs [21].
2.13. RNA electromobility shift assay (EMSA)
RNA gel shift assays for the assessment of RNA-binding capaci-
ties of different HuR truncations were accomplished as described
previously [18]. The sequence of a RNA oligonucleotide corre-
sponded to a region from the 30-UTR of the human LTamRNA from
nucleotide 1182 to 1231 (GenBankTM accession No.
NM-001159740.2) encompassing two adjacent ARE sites (under-
lined) as followed: 50-AGG GGA CUA UUU AUG AAG GCA AAA
AAA UUA AAU UAU UUA UUU AUG GGA-3. Supershift analysis
was performed as described previously [18].
2.14. Statistical analysis
Results are expressed as means ± S.D. Unless indicated other-
wise, experiments were performed at least three times. Statistical
analysis was performed using Student’s t-test.
3. Results
3.1. Reduced expression of LTa in HuR knockdown HepG2 cells
The mRNA coding for the precursor of lymphotoxin a
(LTa) appeared among a previously published list of mRNAs
being signiﬁcantly downregulated in HuR deﬁcient thymocytes
[22]. Since upregulation of LTa is functionally relevant for HCC
[13], we ﬁrst tested LTa expression in HepG2 cells stably
depleted for HuR by a speciﬁc shRNA (HuRk/d). Knockdown efﬁ-
ciency was conﬁrmed by a robust reduction of HuR at the mRNA
(Fig. 1A) and protein level, respectively (Fig. 1B) when compared
to HepG2 cells expressing a non-target shRNA (ctr.). Similarly,
HuR k/d cells revealed a strong and signiﬁcantly reduction in
steady-state LTa mRNA (Fig. 1A) and protein (Fig. 1B) contents.
Subcellular cell fractionation furthermore showed that LTa in
contrast to HuR protein, is mainly localized to the cytoplasm
(Fig. 1C).3.2. Posttranscriptional regulation of LTa mRNA
To analyze whether the HuR depletion-dependent changes in
LTa expression are attributed to a reduced mRNA-stability ctr cells
and HuR k/d cells were treated with actinomycin D (5 lg/mL). A
comparison of the time-dependent mRNA decay in both cell types
by qRT-PCR revealed that the half-life of LTa mRNA was clearly
reduced in HuR deﬁcient cells when compared with control cells
(Fig. 2A, left panel). In contrast, both cell lines displayed a similar
decay of Jun-N-terminal kinase (JNK) encoding mRNA which con-
tains no prototypical HuR binding elements in its 30-UTR and
which is not a target of HuR-dependent mRNA-stabilization [21].
3.3. HuR depleted cells exert a clear shift from polysomes to
ribonucleoprotein particles (RNPs)
As a direct consequence of HuR-dependent stabilization the
HuR-bound mRNA cargo in many cases is increasingly transported
to the translation apparatus and therefore we tested whether the
relative LTa mRNA distribution between inactive RNPs and poly-
somes would be changed upon genetic HuR depletion. Previously,
we could demonstrate that in HepG2 cells inhibitors of the
actin-myosin dependent cytoskeleton can induce a strong change
in polysomal mRNA loading concomitant with a change in the
polysomal HuR allocation [21]. Similar to the changes in intracellu-
lar distribution of some prototypical HuR-target mRNAs [21], the
stable knockdown of HuR caused a clear shift in LTa mRNA abun-
dance from polysomal to RNP fractions (Fig. 2A, right panel). These
data implicate that shRNA-mediated HuR depletion can affect LTa
expression by different posttranscriptional events including
mRNA-stability, mRNA translocation and/or translation.
3.4. Constitutive HuR binding to the 30-UTR of LTa mRNA
Since the 30-UTR of LTa contains two regions with typical HuR
binding signatures (Fig. 2B), we tested for a direct HuR binding
to LTa mRNA in HepG2 cells. Indeed, a strong and constitutive
binding of HuR to LTa mRNA was conﬁrmed by pull-down
RT-PCR assay. Similarly, cyclooxygenase-2 (COX-2) and cyclin A
encoding mRNAs, two well-described HuR targets, showed a con-
stitutive binding with HuR (left panel of Fig. 2B). The speciﬁc
HuR binding to the LTa-30-UTR is proven by biotin pull-down assay
using an in vitro transcribed RNA encompassing the 30-UTR of LTa
(Fig. 2C). In contrast, TTP another prominent ARE-binding protein
highly abundant in HepG2 cells did not attach to LTa mRNA
(Fig. 2C). The fact that HuR binding was strongly impaired if these
AREs had been mutated strongly implicates that HuR binding to
LTamRNA is committed by these cis-regulatory elements (Fig. 2C).
3.5. The 30UTR of LTa mRNA confers reporter gene activation by HuR
To further test whether HuR depletion would affect posttran-
scriptional gene expression driven by the 30UTR of LTa, cells were
transiently transfected with a luciferase reporter gene containing
the complete 30UTR of LTa downstream of the luciferase coding
sequence and under the control of a constitutively active human
simian virus promoter. Correspondingly, cells were transfected
with the empty reporter gene. Importantly, luciferase activity
was signiﬁcantly lower in HuR depleted HepG2 cells than in con-
trol cells if the luciferase gene is under the control of the 30UTR
of LTa (Fig. 3A). In contrast, the knockdown of HuR did not affect
luciferase activity driven by the empty reporter vector (Fig. 3A)
demonstrating that the 30UTR of the LTa mRNA confers HuR
responsiveness.
Accordingly, using EMSA with an RNA oligonucleotide encom-
passing both AREs conﬁrmed a strong binding of a fast migrating
Fig. 1. (A) Downregulation of LTa in HuR depleted HepG2 cells. Control HepG2 cells (ctr.) or HuR depleted HepG2 cells (HuRk/d) were serum-starved for 16 h before the
content of HuR and LTa encoding mRNAs was assessed by quantitative real-time PCR using GAPDH mRNA as a normalization control. Values represent means ± S.D. (n = 4)
and are depicted as – fold induction (***P 6 0.005, *P 6 0.05) compared to control cell levels. (B, C) Cells were treated as described in (A), harvested for either total cell lysates
(B) or nuclear and cytoplasmic cell fractions, respectively (C). Equal amounts of protein (10 lg) from speciﬁc cell fraction were subjected to SDS–PAGE and probed with the
indicated antibodies using b-tubulin (B and C) or HDAC2 (C) as loading control. Data in (B) show densitometric analysis of HuR and LTa relative to b-tubulin in HuR k/d (grey
bars) and control cells (open bars) from three independent experiments and show relative protein levels (%) (***P 6 0.005, **P 6 0.05) compared with the levels of the
corresponding protein in control cells.
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was clearly reduced in the lysates isolated from HuR k/d cells
(Fig. 3B). In a similar manner, GST-tagged HuR displayed the bind-
ing of a major complex which completely disappeared after the
addition of HuR-speciﬁc supershift antibodies (Fig. 3C). In contrast,
GST alone displayed no RNA binding afﬁnity (Fig. 3C).
3.6. Identiﬁcation of HuR domains critical for LTa mRNA-binding
Next, we compared the binding afﬁnity of different GST-HuR
fusion proteins including full-length HuR and various HuR trunca-
tions by EMSA (Fig. 4A). The purity and size of the indicated HuR
constructs was initially conﬁrmed by SDS–PAGE (Fig. 4B, upper
panel). Testing the RNA-binding capacity of these HuR proteins
by EMSA revealed that truncation of the N-terminal RRM1 did
not affect the afﬁnity of HuR to the LTa-speciﬁc RNA oligonu-
cleotide (construct 5) and conversely, RRM1 alone (construct 4)
failed to interact with the same RNA probe (Fig. 4B, lower panel).
Similarly, RRM2 alone (construct 6) and a GST-fusion protein con-
taining the hinge region plus RRM3 (construct 7) exerted no RNAafﬁnity (Fig. 4B, lower panel). Interestingly, deletion of the
C-terminal RRM3 (construct 3) abrogated binding of a fast migrat-
ing complex but did substantially increase the binding of a slow
migrating complex which probably represents a HuR dimer.
These data demonstrate that RRM1 and RRM3 are dispensable for
LTa mRNA-binding. Notably, when loading construct 5, we
observed that, similar to full-length HuR, a main portion of
radioactivity accumulated in the pockets of the EMSA gel. We sug-
gest that the C-terminal RRM3 is not relevant for LTa
mRNA-binding but presumably involved in the formation of larger
RNA-bound HuR complexes which are unable to migrate through
the gel.
4. Discussion
In this study, we have identiﬁed LTa mRNA as a novel target of
HuR-dependent mRNA-stabilization. Functionally, the increase in
LTa mRNA decay observed in stable HuR knockdown cells results
in a signiﬁcant reduction in LTa mRNA levels and is concomitant
with a strongly diminished content of LTa protein (Fig. 1A). We
Fig. 2. LTa mRNA is a target of different HuR-triggered mRNA functions. (A, left panel) Comparison of LTa-mRNA decay after administration of actinomycin D (5 lg/mL) in
ctr. cells (ﬁlled circles) and HuR k/d cells (ﬁlled squares). mRNA levels were quantiﬁed by qRT-PCR using GAPDH as a normalization control. Data show means of a triplicate
experiment as compared to the levels of mRNA measured before the addition of actinomycin D (set as 100%) (A, right panel) The total RNA from polysomal (black bars) and
RNP fractions (white bars) was isolated and the content of the HuR target LTamRNA was measured by qRT-PCR as described in Materials and Methods. The LTamRNA levels
within the indicated fractions are depicted in a relationship to the amount of mRNA pooled from both fractions. Values represent means ± S.D. (n = 3). **P 6 0.01 versus
polysomal fractions (black bars) from control cells; ##P 6 0.01 versus vehicles from RNP fractions (open bars) from control cells and are furthermore depicted as % relative
mRNA distribution. (B) Constitutive binding of HuR to the 30-UTR of LTamRNA in control HepG2 cells. A schematic representation of the LTa-30-UTR and AREs (black boxes) is
shown in the upper panel. (left panel) For the assessment of endogenous HuR-mRNA interactions, HuR was pulled down out of total cell lysates from control HepG2 cells and
HuR-bound mRNAs were subsequently analyzed by semiquantitative RT-PCR using gene-speciﬁc primers from the coding regions (CR). Normalization of similar amounts of
input RNAs added to the IPs was conﬁrmed by RT-PCR. The speciﬁc immunoprecipitation (IP) of HuR was conﬁrmed by western blot analysis shown in the right part of the
panel (C). For biotin pull-down assay a biotinylated transcript encompassing 584 nucleotides of the 30-UTR of human LTa (30-UTR-LTa) or, alternatively, a corresponding
transcript with mutated AREs (30-UTR-LTamut1/2) was incubated with total cell lysates from control HepG2 cells. Speciﬁc binding of HuR was conﬁrmed byWestern blotting
(W. blot).
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LTamRNA with two adjacent ARE motifs being critical for the pro-
tein–RNA interaction (Fig. 2C).
In an attempt to further delineate which HuR domain is
involved in LTa mRNA-binding, we demonstrate that HuR binding
is structurally related to a minimal region encompassing RRM2 and
the hinge domain since deletion of neither the C-terminal RRM3
nor of the N-terminal RRM1 abrogated the afﬁnity of HuR to the
30-UTR of LTa mRNA (Fig. 4B). Furthermore, EMSA results suggest
that RRM3 is involved in the formation of higher molecular weight
HuR complexes which were unable to migrate through the
non-denaturating EMSA gel (Fig. 4B). This observation is in a full
agreement with a previously published study demonstrating that
RRM3 in HuR is mainly required for the cooperative assembly of
HuR oligomers on RNA [23]. In addition, RRM3 was found to be
involved in poly A-binding [24] and relevant for the interaction
with other protein ligands [25].Furthermore, our data indicate that the posttranscriptional reg-
ulation of LTa by HuR is not restricted to T cells but is also relevant
for non-immune cells. Similar to LTa, TNFa another member of the
TNF superfamily is a well described target gene of the RNA-binding
protein HuR [26,27]. Interestingly, in a contrast to HuR, TTP an
ARE-binding protein which is critically involved in posttranscrip-
tional control of TNFa expression [28], could not be detected in
the LTa-biotin pull-down assay (Fig. 2C). Notably, in addition to
TTP a complex network of different RNA binding proteins like
AUF1 and KSRP were shown to compete with HuR for binding to
a common target mRNA [29]. Therefore, it is tempting to speculate
that posttranscriptional regulation of LTa is not solely by HuR but
instead of this determined by the relative abundance and activity
of a set of functionally antagonising and/or cooperating ARE-RNA
binding proteins. Owing to the known preference of some
miRNAs seeds to reside in a close context of AREs and to the
described ability of HuR to modulate miRNA binding, LTa mRNA
Fig. 3. (A) Luciferase assays from control cells (white bars) or HuR k/d cells (grey bars) transfected with either an empty psiCHECK2 vector or with a construct carrying the
complete 30-UTR sequence of human LTa mRNA (psiCHECK2-LTa-30UTR). Renilla luciferase activities for each construct was normalized with Fireﬂy luciferase activities and
are depicted as relative luciferase activities. Data (means ± S.D.) represent the results of three independent experiments. **P 6 0.01; n.s. not signiﬁcant (B). RNA binding of
total cell lysates (5 lg) from control HepG2 cells (ctr.) or HuR k/d cells was analyzed by EMSA using a 32P-labeled RNA probe encompassing two AREs from the 30-UTR of LTa
mRNA (upper panel). A denistometrical analysis of mRNA binding relative to ctr. cells (100%). (C) Similarly, recombinant GST-HuR exerts a high RNA-binding afﬁnity to the 30-
UTR of LTa. For EMSA, 200 ng of bacterially expressed GST-HuR or GST was incubated with the LTa-30-UTR-speciﬁc oligonucleotide shown in (B). For supershift analysis,
200 ng of anti-HuR antibody or mouse IgG were added to the binding reaction. Gel pictures are representative for three independent experiments.
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Fig. 4. Identiﬁcation of HuR domains critical for LTamRNA binding. (A) Schematic representation of constructs coding for different GST-HuR fusion proteins (B). In each lane
1 lg of recombinant protein was loaded on SDS–PAGE and proteins subsequently stained by Coomassie-blue. 32P-labeled RNA probe depicted in panel A was incubated with
the indicated fusion proteins and RNA-binding assessed by EMSA. Positions of the gel pockets are indicated by an arrow.
N. Steinmeyer et al. / FEBS Letters 589 (2015) 1943–1950 1949levels may additionally result from combinatorial posttranscrip-
tional gene regulation by HuR and miRNAs [30].
Mechanistically, LTa via binding and signalling through the TNF
receptors type I and II exhibits overlapping biological activities
with TNFa [13,31]. In the liver, LTa mediated signalling whichinvolves an activation of the classical and alternative NFjB path-
way, was previously identiﬁed as a crucial step in
hepatitis-induced HCC and is therefore considered as a promising
target for novel HCC preventive pharmacotherapies [31].
Pathologically, several lines of evidence gathered from clinical
1950 N. Steinmeyer et al. / FEBS Letters 589 (2015) 1943–1950studies, animal models and cell culture models implicate that HuR
is overexpressed in many tumors. In the liver, HuR seems essential
for the differentiation, proliferation and survival of HCC [13]. For
this reason, besides LTa, HuR emerges as a promising target for
novel anti-tumor therapies. Further studies are needed to conﬁrm
a regulatory role of HuR in the control of LTa expression and its
pathological impact on HCC.
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